LTFS
PTCT icon

Ladenburg Thalmann Financial Services’s PTC Therapeutics PTCT Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$19K Sell
391
-1,001
-72% -$42.5K ﹤0.01% 4181
2019
Q3 		$48K Sell
1,392
-1
-0.1% -$44 ﹤0.01% 3482
2019
Q2 		$63K Sell
1,393
-2
-0.1% -$79 ﹤0.01% 3305
2019
Q1 		$52K Buy
1,395
+1,031
+283% +$34.6K ﹤0.01% 3373
2018
Q4 		$13K Sell
364
-3
-0.8% -$108 ﹤0.01% 4133
2018
Q3 		$17K Sell
367
-65
-15% -$2.69K ﹤0.01% 4004
2018
Q2 		$12K Hold
432
– – ﹤0.01% 4143
2018
Q1 		$12K Sell
432
-5
-1% -$127 ﹤0.01% 4143
2017
Q4 		$8K Sell
437
-485
-53% -$8.21K ﹤0.01% 4313
2017
Q3 		$18K Sell
922
-10,107
-92% -$198K ﹤0.01% 3743
2017
Q2 		$202K Buy
11,029
+508
+5% +$6.84K ﹤0.01% 2016
2017
Q1 		$104K Buy
10,521
+10,277
+4,212% +$124K ﹤0.01% 2379
2016
Q4 		$3K Sell
244
-33
-12% -$346 ﹤0.01% 4434
2016
Q3 		$4K Hold
277
– – ﹤0.01% 4278
2016
Q2 		$2K Sell
277
-12
-4% -$88 ﹤0.01% 4422
2016
Q1 		$2K Sell
289
-23
-7% -$399 ﹤0.01% 4400
2015
Q4 		$10K Buy
312
+8
+3% +$235 ﹤0.01% 3681
2015
Q3 		$8K Buy
+304
New +$13K ﹤0.01% 3678

Other funds holding PTCT

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Ladenburg Thalmann Financial Services's PTCT Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services reduced its PTC Therapeutics (PTCT) stake by 72% in Q4 2019, selling an estimated $42.5K and leaving 391 shares worth $19K. The position accounts for ﹤0.01% of the portfolio, ranked #4181.

Ladenburg Thalmann Financial Services first reported a position in PTCT in Q3 2015 and has held it in 18 quarters since. The position peaked at $202K in Q2 2017. 206 funds tracked by Wall St. Rank hold PTCT as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 391 shares of PTC Therapeutics worth $19K as of Q4 2019.
  • Ladenburg Thalmann Financial Services sold 1,001 PTC Therapeutics shares in Q4 2019, an estimated $42.5K.
  • PTC Therapeutics made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #4181 holding.
  • Ladenburg Thalmann Financial Services first reported a position in PTC Therapeutics in Q3 2015 and has held it in 18 quarters since.
  • Ladenburg Thalmann Financial Services's PTC Therapeutics position peaked at $202K in Q2 2017.
  • 206 funds tracked by Wall St. Rank held PTC Therapeutics as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.